PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER, CONTAINING AN EXTRACELLULAR MATRIX OF MESENCHYMAL STEM CELLS DERIVED FROM UMBILICAL CORD BLOOD AS AN ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition for the treatment of cancer, containing an extracellular matrix (ECM) of mesenchymal stem cells derived from umbilical cord blood as an active ingredient, and more specifically, to a pharmaceutical composition for the treatment of cancer, containing an ECM as an active ingredient, obtained by culturing mesenchymal stem cells derived from umbilical cord blood and removing only cells. The ECM of mesenchymal stem cells derived from umbilical cord blood may suppress the proliferation of various cancers, such as breast cancer, melanoma, pancreatic cancer, liver cancer, gastric cancer, lung cancer, cervical cancer, etc. and minimize problems in manufacturing pharmaceutical or individual deviations when stem cells are used. In addition, side effects, which may occur from the in vivo injection of cells, may be fundamentally prevented.